These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 24435746)

  • 1. Prostate cell lines as models for biomarker discovery: performance of current markers and the search for new biomarkers.
    Johnson IR; Parkinson-Lawrence EJ; Butler LM; Brooks DA
    Prostate; 2014 May; 74(5):547-60. PubMed ID: 24435746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
    Igawa T; Lin FF; Rao P; Lin MF
    Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative analysis of N-linked human glycoproteomic data sets reveals PTPRF ectodomain as a novel plasma biomarker candidate for prostate cancer.
    Whitmore TE; Peterson A; Holzman T; Eastham A; Amon L; McIntosh M; Ozinsky A; Nelson PS; Martin DB
    J Proteome Res; 2012 May; 11(5):2653-65. PubMed ID: 22494190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs and zinc metabolism-related gene expression in prostate cancer cell lines treated with zinc(II) ions.
    Hlavna M; Raudenska M; Hudcova K; Gumulec J; Sztalmachova M; Tanhäuserova V; Babula P; Adam V; Eckschlager T; Kizek R; Masarik M
    Int J Oncol; 2012 Dec; 41(6):2237-44. PubMed ID: 23064315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
    Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
    Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers.
    Sardana G; Jung K; Stephan C; Diamandis EP
    J Proteome Res; 2008 Aug; 7(8):3329-38. PubMed ID: 18578523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitous mitochondrial creatine kinase is overexpressed in the conditioned medium and the extract of LNCaP lineaged androgen independent cell lines and facilitates prostate cancer progression.
    Pang B; Zhang H; Wang J; Chen WZ; Li SH; Shi QG; Liang RX; Xie BX; Wu RQ; Qian XL; Yu L; Li QM; Huang CF; Zhou JG
    Prostate; 2009 Aug; 69(11):1176-87. PubMed ID: 19415690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of PC3 prostate cancer cells with mitoxantrone, etoposide, doxorubicin and carboplatin induces distinct alterations in the expression of kallikreins 5 and 11.
    Thomadaki H; Mavridis K; Talieri M; Scorilas A
    Thromb Haemost; 2009 Feb; 101(2):373-80. PubMed ID: 19190824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The over-expression of Pim-2 promote the tumorigenesis of prostatic carcinoma through phosphorylating eIF4B.
    Ren K; Gou X; Xiao M; Wang M; Liu C; Tang Z; He W
    Prostate; 2013 Sep; 73(13):1462-9. PubMed ID: 23813671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition.
    Coppola V; Musumeci M; Patrizii M; Cannistraci A; Addario A; Maugeri-Saccà M; Biffoni M; Francescangeli F; Cordenonsi M; Piccolo S; Memeo L; Pagliuca A; Muto G; Zeuner A; De Maria R; Bonci D
    Oncogene; 2013 Apr; 32(14):1843-53. PubMed ID: 22614007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell death in irradiated prostate epithelial cells: role of apoptotic and clonogenic cell kill.
    Bromfield GP; Meng A; Warde P; Bristow RG
    Prostate Cancer Prostatic Dis; 2003; 6(1):73-85. PubMed ID: 12664070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the prostate transglutaminase (TGase-4) in prostate cancer cells and its impact on the invasiveness of prostate cancer.
    Davies G; Ablin RJ; Mason MD; Jiang WG
    J Exp Ther Oncol; 2007; 6(3):257-64. PubMed ID: 17552366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
    Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
    Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells.
    Veveris-Lowe TL; Lawrence MG; Collard RL; Bui L; Herington AC; Nicol DL; Clements JA
    Endocr Relat Cancer; 2005 Sep; 12(3):631-43. PubMed ID: 16172196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered endosome biogenesis in prostate cancer has biomarker potential.
    Johnson IR; Parkinson-Lawrence EJ; Shandala T; Weigert R; Butler LM; Brooks DA
    Mol Cancer Res; 2014 Dec; 12(12):1851-62. PubMed ID: 25080433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic significance of overexpression of Golgi membrane protein 1 in prostate cancer.
    Li W; Wang X; Li B; Lu J; Chen G
    Urology; 2012 Oct; 80(4):952.e1-7. PubMed ID: 22840862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of tissue microarrays in prostate cancer biomarker discovery.
    Datta MW; True LD; Nelson PS; Amin MB
    Adv Anat Pathol; 2007 Nov; 14(6):408-18. PubMed ID: 18049130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantified KLK15 gene expression levels discriminate prostate cancer from benign tumors and constitute a novel independent predictor of disease progression.
    Mavridis K; Stravodimos K; Scorilas A
    Prostate; 2013 Aug; 73(11):1191-201. PubMed ID: 23620432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP.
    Iwasa Y; Mizokami A; Miwa S; Koshida K; Namiki M
    Int J Urol; 2007 Mar; 14(3):233-9. PubMed ID: 17430262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of cellular prostatic acid phosphatase increases tumorigenicity of human prostate cancer cells.
    Lin MF; Lee MS; Zhou XW; Andressen JC; Meng TC; Johansson SL; West WW; Taylor RJ; Anderson JR; Lin FF
    J Urol; 2001 Nov; 166(5):1943-50. PubMed ID: 11586265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.